Merit Medical Systems, Inc.
HealthcareNASDAQ:MMSI · NASDAQ Global Select
-$0.36 today
Vol 0.48M · Avg 0.79M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
8.1%
avg 4.8%
ROIC
5.6%
avg 3.6%
ROA
4.8%
avg 2.8%
Analysis
ROE is currently the strongest return metric at 8.1% versus its period average of 4.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Neil Peterson | Chief Operating Officer | $1.26M | — | 59 | $53,061.00 | 0.09% |
Raul Parra Jr. | Chief Financial Officer & Treasurer | $1.24M | — | 47 | $58,843.00 | 0.10% |
Brian G. Lloyd | Chief Legal Officer & Corporate Secretary | $1.22M | — | 65 | $60,132.00 | 0.10% |
Michel J. Voigt | Chief Human Resources Officer | $816,792.00 | — | 53 | $0.00 | <0.01% |
Martha Goldberg Aronson | President, Chief Executive Officer & Director | $501,385.00 | — | 59 | $49,792.00 | 0.08% |
Jason Treft | Chief Information Officer | — | — | — | — | — |
Mark Butler | Executive Vice President of Merit Medical EMEA | — | — | — | — | — |
Alisha Jerauld | Sustainability Council Chair and Vice President of Environment, Social & Governance | — | — | — | — | — |
John Knorpp | Chief Regulatory Affairs Officer | — | — | — | — | — |
Sarah Comstock | Vice President of Global Communications | — | — | — | — | — |
Ricardo Alvarez | Managing Director of Operation Merit Medical Tijuana | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
5
$573,293.50
Sells
9
$7.85M
Net Sentiment
$7.28M
Net selling
Most Active
Lampropoulos Fred P.
4 transactions
1–10 of 14
Analysis
Insiders reported 5 buys worth $573,293.50 and 9 sells worth $7.85M over the last 12 months. That adds up to net selling of $7.28M. Lampropoulos Fred P. was the most active insider with 4 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +4.8% | +16.7% (15yr)1 analysts |
| Revenue | N/A | N/A | +11.2% | +9.2% (15yr)3 analysts |
| Net Income | N/A | N/A | +6.5% | +19.0% (15yr)3 analysts |
| EBIT | N/A | N/A | +8.2% | +11.5% (15yr)3 analysts |
Analysis
Recent growth has been strongest in Revenue at +11.2% over three years. Forward estimates point to Net Income at +19.0% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Krystal Biotech, Inc.
NASDAQ:KRYS
$9.37B
Bruker Corporation
NASDAQ:BRKR
$8.26B
TG Therapeutics, Inc.
NASDAQ:TGTX
$7.58B
Glaukos Corporation
NYSE:GKOS
$7.45B
Alkermes plc
NASDAQ:ALKS
$7.38B
PTC Therapeutics, Inc.
NASDAQ:PTCT
$6.23B
Teleflex Incorporated
NYSE:TFX
$5.78B
Bausch + Lomb Corporation
NYSE:BLCO
$5.38B
Stevanato Group S.p.A.
NYSE:STVN
$4.66B
TransMedics Group, Inc.
NASDAQ:TMDX
$2.52B
Who manages MMSI?
Merit Medical Systems, Inc. (MMSI) lists 11 active executives. The top listed executive is Raul Parra Jr., Chief Financial Officer & Treasurer.
Are MMSI insiders buying or selling?
Recent insider activity shows net selling of $46.83M.
Explore More
Continue the stock analysis
Jump to another research area for this company.